Aerie Pharmaceuticals Inc...

NASDAQ: AERI · Real-Time Price · USD
15.25
0.00 (0.00%)
At close: Nov 18, 2022, 10:00 PM

Aerie Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2021
Period Ending Dec 31, 2021
Revenue
194.13M
Cost of Revenue
26.85M
Gross Profit
167.29M
Operating Income
-45.31M
Interest Income
139K
Pretax Income
-74.22M
Net Income
-74.81M
Selling & General & Admin
137.81M
Research & Development
75.84M
Other Expenses
n/a
Operating Expenses
213.64M
Interest Expense
28.9M
Selling & Marketing Expenses
n/a
Cost & Expenses
240.49M
Income Tax Expense
593K
Shares Outstanding (Basic)
46.34M
Shares Outstanding (Diluted)
46.34M
EPS (Basic)
-1.61
EPS (Diluted)
-1.61
EBITDA
-7.81M
EBIT
-44.27M
Depreciation & Amortization
37.5M